ATE292462T1 - Behandlung von asthma anhand von mek-inhibitoren - Google Patents
Behandlung von asthma anhand von mek-inhibitorenInfo
- Publication number
- ATE292462T1 ATE292462T1 AT99968153T AT99968153T ATE292462T1 AT E292462 T1 ATE292462 T1 AT E292462T1 AT 99968153 T AT99968153 T AT 99968153T AT 99968153 T AT99968153 T AT 99968153T AT E292462 T1 ATE292462 T1 AT E292462T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- asthma
- mek inhibitors
- administering
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11508699P | 1999-01-07 | 1999-01-07 | |
PCT/US1999/030419 WO2000040235A2 (en) | 1999-01-07 | 1999-12-21 | Treatment of asthma with mek inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE292462T1 true ATE292462T1 (de) | 2005-04-15 |
Family
ID=22359251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99968153T ATE292462T1 (de) | 1999-01-07 | 1999-12-21 | Behandlung von asthma anhand von mek-inhibitoren |
Country Status (9)
Country | Link |
---|---|
US (2) | US6696440B1 (de) |
EP (1) | EP1140062B1 (de) |
JP (1) | JP2002534380A (de) |
AT (1) | ATE292462T1 (de) |
AU (1) | AU2483000A (de) |
BR (1) | BR9916785A (de) |
CA (1) | CA2350234A1 (de) |
DE (1) | DE69924641D1 (de) |
WO (1) | WO2000040235A2 (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7345051B2 (en) | 2000-01-31 | 2008-03-18 | Genaera Corporation | Mucin synthesis inhibitors |
PT1255544E (pt) | 2000-01-31 | 2007-06-15 | Genaera Corp | Inibidores da síntese da mucina. |
CN1219753C (zh) | 2000-07-19 | 2005-09-21 | 沃尼尔·朗伯公司 | 4-碘苯氨基苯氧肟酸的氧合酯 |
EP1344525A4 (de) | 2000-12-22 | 2005-05-25 | Ishihara Sangyo Kaisha | Anilinderivate oder ihre salze und diese enthaltende zytokinproduktion-inhibitoren |
NZ518726A (en) | 2001-05-09 | 2004-06-25 | Warner Lambert Co | Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor |
DOP2003000556A (es) * | 2002-01-23 | 2003-10-31 | Warner Lambert Co | Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico. |
US7235537B2 (en) * | 2002-03-13 | 2007-06-26 | Array Biopharma, Inc. | N3 alkylated benzimidazole derivatives as MEK inhibitors |
PT3000810T (pt) | 2002-03-13 | 2017-10-25 | Array Biopharma Inc | Derivados de benzimidazole alquilado n3 como inibidores de mek |
US7144907B2 (en) | 2003-09-03 | 2006-12-05 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
US7538120B2 (en) | 2003-09-03 | 2009-05-26 | Array Biopharma Inc. | Method of treating inflammatory diseases |
CA2542210A1 (en) | 2003-10-21 | 2005-05-06 | Warner-Lambert Company Llc | Polymorphic form of n-[(r)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide |
US7517994B2 (en) | 2003-11-19 | 2009-04-14 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
US7732616B2 (en) * | 2003-11-19 | 2010-06-08 | Array Biopharma Inc. | Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof |
JP4768628B2 (ja) | 2003-11-19 | 2011-09-07 | アレイ バイオファーマ、インコーポレイテッド | Mekの二環系阻害剤及びその使用方法 |
AU2004293026B2 (en) | 2003-11-21 | 2012-01-19 | Array Biopharma Inc. | AKT protein kinase inhibitors |
UA89035C2 (ru) * | 2003-12-03 | 2009-12-25 | Лео Фарма А/С | Эфиры гидроксамовых кислот и их фармацевтическое применение |
EP1737475A4 (de) * | 2004-03-19 | 2009-08-05 | Xiu-Min Li | Pflanzliche therapie zur behandlung von asthma |
PL1761528T3 (pl) | 2004-06-11 | 2008-05-30 | Japan Tobacco Inc | Pochodne 5-amino-2,4,7-triokso-3,4,7,8-tetrahydro-2H-pirydo[2,3-D]pirymidyny i związki pokrewne do leczenia raka |
US7378423B2 (en) | 2004-06-11 | 2008-05-27 | Japan Tobacco Inc. | Pyrimidine compound and medical use thereof |
SG177981A1 (en) * | 2005-05-18 | 2012-02-28 | Array Biopharma Inc | 4-(phenylamino)-6-oxo-1, 6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases |
PL1934174T3 (pl) | 2005-10-07 | 2011-09-30 | Exelixis Inc | Azetydyny jako inhibitory w leczeniu chorób proliferacyjnych |
AU2006306991A1 (en) | 2005-10-28 | 2007-05-03 | Takeda Pharmaceutical Company Limited | Heterocyclic amide compound and use thereof |
WO2008006039A1 (en) | 2006-07-06 | 2008-01-10 | Array Biopharma Inc. | Dihydrothieno pyrimidines as akt protein kinase inhibitors |
US8063050B2 (en) | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
UA99597C2 (ru) | 2006-07-06 | 2012-09-10 | Еррей Біофарма Інк. | Пиримидилциклопентаны как ингибиторы акт протеинкиназ |
DE602007011628D1 (de) | 2006-07-06 | 2011-02-10 | Array Biopharma Inc | Dihydrofuropyrimidine als akt-proteinkinaseinhibitoren |
CN101605540A (zh) | 2006-12-14 | 2009-12-16 | 埃克塞利希斯股份有限公司 | 使用mek抑制剂的方法 |
CA2692502C (en) | 2007-07-05 | 2016-03-01 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
EP2173723B3 (de) | 2007-07-05 | 2014-11-19 | Array Biopharma Inc. | Pyrimidylcyclopentane als inhibitoren der akt-proteinkinase |
US9409886B2 (en) | 2007-07-05 | 2016-08-09 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
US8846683B2 (en) | 2007-07-05 | 2014-09-30 | Array Biopharma, Inc. | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
NZ586418A (en) | 2007-12-19 | 2012-09-28 | Cancer Rec Tech Ltd | Pyrido[2,3-b]pyrazine-8-substituted compounds and their use |
WO2009089459A1 (en) | 2008-01-09 | 2009-07-16 | Array Biopharma Inc. | Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
KR101624752B1 (ko) | 2008-01-09 | 2016-05-26 | 어레이 바이오파마 인크. | Akt 단백질 키나제 저해물질로써의 수산화된 피리미딜 시클로펜탄 |
BRPI0908708A2 (pt) | 2008-03-17 | 2019-09-24 | Scripps Research Inst | métodos para produzir células tronco pluripotentes induzidas a partir de células não pluripotentes de mamífero, para triar quanto a agentes que induzam a reprogramação ou desdiferenciação de células de mamífero dentro das células tronco pluripotentes, para triar quanto a células de mamífero com características de células tronco pluripotente, para induzir a expressão de oct4 em uma célula e para induzir células não pluripotentes em células pluripotentes, mistura, célula de mamífero, métodos para produzir células tronco pluripotentes induzidas a partir de células não pluripotentes de mamífero, para triar quanto a agentes que induzam a reprogramação ou desiferenciação de células de mamífero dentro das células tronco pluripotentes, para triar quanto a células de mamífero com características de célula tronco pluripotente, para induzir a expressão de oct4 em uma célula e para induzir células não pluripotentes em células pluripotentes, mistura, célula de mamífero, composição, e, kit |
WO2010051933A2 (en) | 2008-11-10 | 2010-05-14 | Bayer Schering Pharma Aktiengesellschaft | Substituted sulphonamido phenoxybenzamides |
CA2777430A1 (en) | 2009-10-21 | 2011-04-28 | Bayer Pharma Aktiengesellschaft | Substituted benzosulphonamides |
EP2491015A1 (de) | 2009-10-21 | 2012-08-29 | Bayer Pharma Aktiengesellschaft | Substituierte benzosulfonamide |
WO2011047796A1 (en) | 2009-10-21 | 2011-04-28 | Bayer Schering Pharma Aktiengesellschaft | Substituted halophenoxybenzamide derivatives |
BR112012018415A2 (pt) | 2010-02-01 | 2020-08-04 | Cancer Research Technology Limited | composto, composição, métodos de preparar uma composição e de tratamento, e, uso de um composto. |
CN103221043B (zh) | 2010-08-05 | 2016-04-06 | 卡斯西部储备大学 | 用于治疗神经元连接发育障碍的erk抑制剂 |
JP2013542214A (ja) | 2010-10-29 | 2013-11-21 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 置換フェノキシピリジン類 |
CN114164167A (zh) | 2010-12-22 | 2022-03-11 | 菲特治疗公司 | 用于单细胞分选与增强ipsc重新编程的细胞培养平台 |
TR201815685T4 (tr) | 2011-04-01 | 2018-11-21 | Genentech Inc | Kanser tedavisi için akt ve mek inhibe edici bileşiklerin kombinasyonları. |
CA2844699C (en) | 2011-04-01 | 2019-05-07 | Genentech, Inc. | Combinations of akt inhibitor compounds and abiraterone, and methods of use |
NZ706723A (en) | 2012-10-12 | 2018-07-27 | Exelixis Inc | Novel process for making compounds for use in the treatment of cancer |
GB201320729D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
GB201320732D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Methods of chemical synthesis |
EP3604499A1 (de) | 2014-03-04 | 2020-02-05 | Fate Therapeutics, Inc. | Verbesserte neuprogrammierungsverfahren und zellkulturplattformen |
CA3001917A1 (en) | 2015-10-16 | 2017-04-20 | Fate Therapeutics, Inc. | Platform for the induction & maintenance of ground state pluripotency |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5525625A (en) * | 1995-01-24 | 1996-06-11 | Warner-Lambert Company | 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders |
US6143728A (en) * | 1996-11-15 | 2000-11-07 | The Picower Institute For Medical Research | Guanylhydrazones useful for treating diseases associated with T cell activation |
AU5610398A (en) * | 1997-02-28 | 1998-09-18 | Warner-Lambert Company | Method of treating or preventing septic shock by administering a mek inhibitor |
JP4621355B2 (ja) * | 1999-01-13 | 2011-01-26 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | ベンゾ複素環およびmek阻害剤としてのその使用 |
-
1999
- 1999-12-21 AU AU24830/00A patent/AU2483000A/en not_active Abandoned
- 1999-12-21 BR BR9916785-9A patent/BR9916785A/pt not_active IP Right Cessation
- 1999-12-21 DE DE69924641T patent/DE69924641D1/de not_active Expired - Lifetime
- 1999-12-21 WO PCT/US1999/030419 patent/WO2000040235A2/en active IP Right Grant
- 1999-12-21 JP JP2000591992A patent/JP2002534380A/ja active Pending
- 1999-12-21 EP EP99968153A patent/EP1140062B1/de not_active Expired - Lifetime
- 1999-12-21 CA CA002350234A patent/CA2350234A1/en not_active Abandoned
- 1999-12-21 US US09/889,091 patent/US6696440B1/en not_active Expired - Fee Related
- 1999-12-21 AT AT99968153T patent/ATE292462T1/de not_active IP Right Cessation
-
2004
- 2004-01-07 US US10/753,170 patent/US20040141924A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2350234A1 (en) | 2000-07-13 |
AU2483000A (en) | 2000-07-24 |
EP1140062B1 (de) | 2005-04-06 |
JP2002534380A (ja) | 2002-10-15 |
US6696440B1 (en) | 2004-02-24 |
DE69924641D1 (de) | 2005-05-12 |
BR9916785A (pt) | 2001-10-23 |
WO2000040235A3 (en) | 2000-11-09 |
EP1140062A2 (de) | 2001-10-10 |
US20040141924A1 (en) | 2004-07-22 |
WO2000040235A2 (en) | 2000-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE292462T1 (de) | Behandlung von asthma anhand von mek-inhibitoren | |
ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
NZ515567A (en) | Method for treating chronic pain using MEK inhibitors | |
CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
ATE395052T1 (de) | Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes | |
ATE362363T1 (de) | Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden | |
TR200200204T2 (tr) | MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi. | |
ATE399782T1 (de) | Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen | |
MXPA05006359A (es) | Tratamiento de la enfermedad a traves de inhibidores peptidos antimicrobianos. | |
ATE301995T1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
DE602006010442D1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen | |
SE0104248D0 (sv) | Method of treatment | |
CY1109037T1 (el) | Πιπεραζινες χρησιμες για θεραπεια πονου | |
ATE382346T1 (de) | Verfahren zur behandlung von krankheiten mit hsp90-hemmenden mitteln in kombination mit antimetaboliten | |
DE60327557D1 (de) | Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie | |
DE69920205D1 (de) | Verwendung von metall-proteinase-inhibitoren, um das wachstum der haare oder körperhaare zu induzieren und/oder zu stimulieren und/oder den haarausfall zu verlangsamen | |
IL165259A (en) | Compounds useful in the treatment of anthrax and inhibiting lethal factor | |
DE69822626D1 (de) | Verwendung eines nitroxids oder seiner prodrugs zur prophylaktischen und therapeutischen behandlung von krebs | |
ATE297739T1 (de) | Endothelin-antagonisten zur behandlung von herzversagen | |
SE0301883D0 (sv) | New use II | |
DE60220825D1 (de) | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks | |
MXPA05010800A (es) | Acidos hidroxamicos utiles en el tratamiento de trastornos hiperproliferativos. | |
ATE291434T1 (de) | Verwendung von angiotensin zur behandlung von krebsmetastasierung | |
DE60121978D1 (de) | 7-CHLOR-4-HYDROXY-2-(2-PYRIDYLETHYL)-1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON SCHMERZEN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |